Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report
Background: Due to its unique pharmacologic properties, efficacy as an analgesic, and role as a first-line medication for the treatment of opioid use disorder, sublingual buprenorphine has emerged as a treatment for patients with concurrent chronic pain and opioid use disorders. One challenge to uti...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Canadian Journal of Pain |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/24740527.2019.1599279 |